Khiron Life Sciences (Khiron Life Sciences) EBIT per Share : $0.00 (TTM As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Khiron Life Sciences EBIT per Share?

Khiron Life Sciences's EBIT per Share for the three months ended in Sep. 2022 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 32.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Khiron Life Sciences's EBIT per Share or its related term are showing as below:

KHRWF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -100.8 Med: 8.5 Max: 40.3
Current: 32.2

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Khiron Life Sciences was 40.30% per year. The lowest was -100.80% per year. And the median was 8.50% per year.

KHRWF's 3-Year EBIT Growth Rate is not ranked
in the Drug Manufacturers industry.
Industry Median: 7.25 vs KHRWF: 32.20

Khiron Life Sciences's EBIT for the three months ended in Sep. 2022 was $-2.52 Mil.

Khiron Life Sciences EBIT per Share Historical Data

The historical data trend for Khiron Life Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences EBIT per Share Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

EBIT per Share

Get a 7-Day Free Trial

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-	-

Khiron Life Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Khiron Life Sciences's EBIT per Share for the fiscal year that ended in Dec. 2021 is calculated as

	EBIT per Share		(A: Dec. 2021 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-25.898	/	0
=	N/A

Khiron Life Sciences's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

	EBIT per Share		(Q: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.517	/	0
=	N/A

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Khiron Life Sciences (OTCPK:KHRWF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Khiron Life Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRWF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.